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Cytolytic lymphocytes provide a host resistance mechanism that may be exerted
against tumors, allografts, and cells infected with microbial agents, especially viruses
and some bacteria . There are several types ofkiller cells (1): antigen-specific, MHCrestricted CTL, as well as lymphokine-activated killer (LAK) , and NK cells, which
have less well-defined specificities.
Cytolytic lymphocytes are typically generated in tissue culture using heterogeneous populations of both responder lymphocytes and APCs, as well as some source
ofexogenous growth factors and other cytokines. Under such conditions, the proliferative and lytic responses by CD8+ lymphocytes are enhanced by the lymphokine
products of helper GD4 + cells, especially IL-2 (2-5) . However, murine lymphocytes
depleted of CD4 + T cells can also independently generate CTL directed against
viral (6) and transplantation antigens (7-10) . This development of CTL from helperdepleted populations is induced by dendritic cells and is accompanied by the release
of IL-2 (9). In man the cellular requirements for Cytolytic lymphocyte development
have not been similarly analyzed, and it is often assumed that helper cells are essential. We will show here that it is possible to induce Cytolytic cells from purified human
CD4 - lymphocyte populations in the primary MLR, as long as dendritic cells are
used as the stimulator cells or APCs . The use of human cells has enabled us to describe several new features of the helper-independent response. Whereas in the murine MLR it is necessary to use heterologous serum in the cultures, and macrophages are inhibitory, the human response occurs in homologous serum, and
monocytes are neither stimulatory nor inhibitory. We will also demonstrate that both
antigen-specific CTL and antigen-nonspecific NK cells can be induced by human
dendritic cells, and that the number of cells that transform into blasts and express
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activation antigens is very high, as many as 30-40% of the cultured cells at day
4-5 of the primary MLR .
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Materials and Methods
Culture Medium, Serum, Buffers . Cells were cultured in RPMI 1640 (Gibco Laboratories,
Grand Island, NY) supplemented with 1 mM glutamine (KC Biological, Lenexa, KS), 5 x
10-5 M 2-ME (Eastman Kodak, Rochester, NY), penicillin (100 Units/ml), streptomycin (100
Wg/ml) (Gibco Laboratories), and 10% serum. FCS (HyClone Laboratories, Sterile Systems,
Logan, UT) was heat inactivated for 30 min at 56'C. Normal human serum (NHS) was
obtained by venipuncture from fasting, healthy, untransfused male volunteer donors, clotted
in the presence of glass shards for 1 h at room temperature . The serum was clarified by centrifugation (1,5008, 15 min), heat inactivated at 56°C for 30 min, and stored at -20 °C until
needed . Ca 2'_ and Mgt+-free saline buffers were used for all washes, either as PBS or as
HBSS.
Normal leukocyte concentrates
PBMC and Preparation of Leukocyte Subpopulations (11).
(Greater NY Blood Program, New York, NY; specimens yielding positive serology for hepatitis B or HIV were not used) were layered over Ficoll-Paque (Pharmacia Fine Chemicals,
Piscataway, NJ) and centrifuged at 1,000 8 for 20 min at room temperature . The cellular
interface was collected as a source of PBMC, washed in PBS or HBSS, and separated over
continuous Percoll density gradients as previously described (11). Low density cells from this
primary Percoll separation were used as a source of monocytes, and were further enriched
if necessary by an adherence step on tissue culture plastic . The high density fraction was
rosetted with neuraminidase-treated (Vibrio cholerae neuraminidase ; Calbiochem-Behring Diagnostics, La Jolla, CA) sheep erythrocytes (Scott Laboratories, Fiskeville, RI), and separated over Ficoll-Paque into erythrocyte rosette-negative (Er-) and erythrocyte rosette-positive (Er+) fractions . The Er` fraction was further purified by passage over a nylon wool
column (Fenwal Laboratories, Deerfield, IL) and used as a source of T cells . The Er- fraction was cultured for -36 h, panned over human Ig-coated plates to deplete contaminant
monocytes, and then separated over a secondary Percoll gradient (11). Secondary low density
cells were used as an enriched source of DCs, whereas the secondary high density fraction
was predominantly B lymphocytes. This method routinely yielded an accessory cell population of dendritic cells enriched to 40-80% purity (11).
An alternative simpler approach was to omit the first Percoll separation. Bulk mononuclear
cells were directly rosetted with neuraminidase-treated sheep erythrocytes for separation into
Er- and Er' fractions as above . The Er- cells were cultured in RPMI-10% NHS . Er cells
that remained adherent after -36 h of culture, or that readhered to tissue culture plastic
after -36 h culture, were used as a highly enriched source of monocytes with no difference
in the functional results described below. Er nonadherent cells were panned twice over
human Ig-coated plates to deplete monocytes (11), then separated over a continuous Percoll
density gradient to yield a DC-enriched low density fraction. The high density fraction from
this separation again consisted primarily of small B lymphocytes .
Cell Phenotype Analysis . The following mAbs were used either as purified Ig or as hybridoma
supernatants : anti-CD3 (OKT3/IgG2a, ATCC CRL 8001); anti-CD4 (Leu3a/IgGI, gift
of Dr. Robert Evans [New York, NY] ; OKT4/IgG2a, ATCC CRL 8002) ; anti-CD8
(OKT8/IgG2a, ATCC CRL 8014); "Simultest" anti-CD4-FITC/anti-CD8-PE (Leu3a/IgGlFITC//Leu2a/IgGl-PE, Becton-Dickinson [B-D], Mountain View, CA) ; anti-CD11b
(OKMI/IgG2b, ATCC); anti-CD14 (3C10/IgG26, ATCC TIB 228); anti-CD16 (3G8/IgGl,
gift of Dr. Jay Unkeless [New York, NY] ; Leullc/IgGI, B-D); anti-CD25 (antiTAC/IgG2a,
gift of Dr. T. Waldman [Bethesda, MD]); anti CD28 (9.3/IgG2b, gift of Dr. Paul Martin
[Seattle, WA]); anti-CD45R (Leu18/IgGI, B-D); anti-HLA DR/DQmonomorphic epitope
(9 .3F10/IgG2a, ATCC HB 180); antiTCR a//3 chains (antiTCRI/IgGI, B-D); antiTCR 6
chain, common region (IgGI ; T Cell Sciences, Cambridge, MA) . In some cases, the mAbs
were directly conjugated with either FITC or PE; otherwise FITC-conjugated F(ab')2 goat
anti-mouse IgG + IgM (Grub, Scandic, Vienna, Austria) was used as a second-step reagent

YOUNG AND STEINMAN

1317

Downloaded from https://rupress.org/jem/article-pdf/171/4/1315/487882/1315.pdf by Rockefeller University user on 21 July 2020

for indirect staining. Stained cells were analyzed by cytofluorography on a FACScan instrument (Becton-Dickinson Immunocytometry Systems, Mountain View, CA) .
Purification of T Lymphocyte Subsets. Enriched populations of CD4' and CD8' T cells were
purified by negative selection of antibody-coated lymphocytes, panned on goat anti-mouse
IgG-coated petri dishes. Briefly, Er' nylon wool nonadherent lymphocytes at 5-7 x 106
cells/ml were coated with hybridoma supernatants on ice for 30-45 min, at concentrations
previously determined to yield strongly positive fluorescence. The cell suspensions were washed
three times in RPMI-57o FCS before panning. Pans were prepared using 60 or 100 mm
bacteriologic grade petri dishes (Falcon 1007 or 1005; Becton-Dickinson, Lincoln Park, NJ),
coated for 1 h at room temperature with 20 or 60 ug, respectively, of IgG fraction goat
anti-mouse IgG (Fc fragment ; .y chain specific, Cappe10211-0121 ; Cooper Biomedical, Malvern, PA) in PBS. These dishes were gently rinsed four times with cold PBS just before use.
The mAb-coated lymphocytes were resuspended in cold RPMI-5% FCS at 5 x 106 cells/ml,
and either 3 or 8 ml was added to 60- or 100-mm dishes, respectively. The pans were centrifuged at 25 g at 4°C for 5 min in a swinging bucket rotor (Sorvall RC3B, rotor H6000A)
with slow acceleration and no brake . The pans were swirled and rotated 180°, then centrifuged
again in the same manner. Thereafter, nonadherent lymphocytes were gently washed from
the pans, and their purity as a negatively selected population was monitored by cytofluorography (Fig. 1).
Panning was also used to deplete NK cells contained within a subpopulation of CDllb'/
CD28- and CD16' cells comprising part of the CD4 - fraction (Fig. 1). This subset could
be depleted by adding the anti-CD11b mAb, OKMI, to the panning procedure . As shown
in Fig. 1, the starting Er' nylon wool nonadherent cells ("bulk T cells," left column of Fig.
1) contained major CD4' and CD8' subsets and minor fractions of cells that were
CDllb'/CD28- and CD16'. Inclusion of the anti-CDllb mAb OKMI, when removing CD4'
lymphocytes by panning, yielded populations depleted of the minor CD11b'/CD28-, CD16'
(right column of Fig. 1), and CD57' (not shown) subsets . The effect of OKMI was specific
since the CD11b subset was not depleted when anti-CD14/3C10 was used as a nonreactive,
isotype-matched control mAb for anti-CDllb/OKMI . The phenotype of these starting cell
populations was also maintained following stimulation in culture with allogeneic DCs (cf,
Results, Fig. 5).
Mixed Leukocyte Reactions. Stimulatory APCs for the human MLR were either bulk mononuclear cells or one of the Er subsets enriched in monocytes, dendritic cells, or small B lymphocytes, as described above. APCs were irradiated (3,000 rad, "'Cs) and added to T lymphocytes at APC/T ratios of 1 :10 or lower, as indicated in the respective experiments . MLRs
were uniformly cultured in the presence ofRPMI-10% NHS, either in 16-mm, 24-well, flatbottomed (1 .5 x 106 T cells), 96-well flat-bottomed (1 .5 or 2 x 105 T cells), or 96-well Ubottomed (1 x 105 T cells) tissue culture plates (Costar, Cambridge, MA), according to the
needs of the particular experiment. The cultures were maintained at 37°C in humidified
6% C02 .
Proliferative activity in the MLR was measured by the incorporation of ['H]TdR (New
England Nuclear, Boston, MA) in the DNA of replicating cells . When MLRs were run in
16-mm macrowells, triplicate 100-p,1 aliquots were transferred to U-bottomed microwells, to
which 1 /,Ci ['H]TdR per well was added. MLRs cultured in microwells from the outset
were pulsed similarly. After 6 h of incubation, the wells were harvested on glass fiber filters
and counted . Responses have been reported as the mean cpm of triplicates .
Assay of T Cell Growth Factor in the MLR. Aliquots of MLR supernatants were harvested
at representative time points, frozen, then thawed and added in serial dilutions to cells from
the CTLL2 line in flat-bottomed microwells. 1 tiCi [3H]TdR was added to each microwell
at 18-24 h, and DNA synthesis in the presence of the MLR supernatants was compared with
that of CTLL2 cells cultured with graded doses of rIL-2 (reference 12; Biogen, Cambridge,
MA) . The amount of T cell growth factor in the MLR supernatants was then expressed in
terms of units per milliliter of rIL-2 .
Cytolytic T Lymphocyte Assay. Cytolytic activity derived from the MLR was measured in
a standard 4-h 5 'Cr-release assay. When the MLRs were cultured in 16-mm macrowells, the
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FIGURE 1.

Phenotype of starting lymphocyte responders in the allogeneic MLR (cf., Fig. 5) .
Er*, nylon wool nonadherent [NyW NA] lymphocytes were used as bulk T cells. The two CD8'
enriched populations were CD4-/CD14- and CD4-/CDllb - lymphocytes negatively selected by
panningwith anti-CD4/OKT4 and either anti-CD14/3C10 (negative control) or anti-CDllb/OKMl.
Each population was stained with the indicated mAbs and analyzed by cytofluorography. In the
two-color analyses, anti-CD8/Leu2a-PE is shown along the ordinate, andanti-CD4/Leu3a-FITC
is illustrated along the abscissa . In the single color histograms, either FITC-conjugated mAbs
or two-step indirect staining with FITC-goat anti-mouse Ig and primary mAbs was used to determine logo fluorescence along the abscissa . Major subpopulations of CD28' and CD3* lymphocytes are indicated (-) in the middle and bottom rows, respectively. Minor subpopulations
of CDIlb' and CD16' lymphocytes are indicated by (- - -) in the middle and bottom rows,
respectively. Negative controls stained with FITC-goat anti-mouse Ig but no primary mAb are
indicated by the unlabeled, dotted lines.
cells were harvested and transferred in graded doses to U-bottomed microwells, to which
5 or 10 x 10' radiolabeled target cells were added. Alternatively, when the MLRs were cultured initially in U-bottomed microwells, the cells were gently resuspended; and 5 x 10' radiolabeled targets were added directly to the MLR microwells . CTL assays were run in triplicates for each experimental condition.
Cultured human macrophages were routinely used as allogeneic and syngeneic target cells
for CTL assays . Monocytes were cultured in RPMI-10% NHS in Teflon beakers and labeled
with "Cr (New England Nuclear) as previously reported (13) . The K562 cell line was "Crlabeled and used as targets for measurement of antigen-nonspecific lytic activity.
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The microtiter plates were incubated at 37'C, 617o C02 for 4 h. Thereafter, the plates were
spun at 15 g for 5 min at 37'C, and supernatant aliquots were harvested to measure 5 'Cr
release. Spontaneous release was measured from target cells cultured without effectors in
medium only, and total release was measured from targets cultured in 0.1% SDS. Cytolytic
activity has been reported as the percent specific release of 5 'Cr, calculated in standard
fashion as: percent specific release = 100 x [(mean cpm from triplicate test wells - spontaneous release)/(total release - spontaneous release)] . Spontaneous release was always <10-15%
of the total release for the experiments reported here.

stimulator cells in the human MLR, i.e., bulk mononuclear cells from peripheral
blood, is unable to stimulate allogeneic CTL in the absence of CD4+ lymphocytes
and their secreted "helper" lymphokines (14). Our initial goal was to test if, using
dendritic cells as APC, one could elicit responses from the CD4 - population of
human blood lymphocytes . This was indeed the case in that allogeneic dendritic
cells could induce the formation ofkillers that would preferentially attack allogeneic
vs. syngeneic monocytes as targets (Fig. 2). However, we noted that dendritic cells
also stimulated the formation of nonspecific killers, as evidenced by lysis of K562
target cells (Fig. 2).
It has been reported that all mature CD4 - lymphocyte effectors derive from one
of two precursor subsets characterized by reciprocal CD28 `/CDllb - "cytolytic" and
CD28 - /CDllb+ "suppressor" phenotypes (15, 16). We tested if OKM1, an IgG2b
mAb against the CR3/CD11b epitope, could be used to deplete precursors of K562
lytic cells. Anti-C134 and anti-CDllb mAb were used together to pan populations
of nylon wool nonadherent lymphocytes (cf. Fig . 1 and Materials and Methods for
the efficiency of the panning procedure). 3010, a nonreactive IgG2b anti-CD14 mAb,
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FicURE 2 . Cytolytic activity derived
from primary MLRs stimulated by allogeneic blood dendritic cells . Lymphocyte responder populations were obtained as described under Materials
and Methods and Fig . 1 (bulk T lym
I; CD4 - /CD14 - lymphophocytes,
cytes, 0 ; CD4 - /CDllb - lymphocytes, ®) and stimulated by allogeneic blood dendritic cells (3,000 rad,
1 ;7 Cs) in U-bottomed microwells in
RPMI-10% NHS (responder/ stimulator ratio of 25 :1) . After 4-5 d of culture, the cell targets indicated along the
abscissa were "Cr-labeled, and 5 x
]0' targets were added directly to the
microwells . PHA (10,ug/ml final) was
added to a parallel cohort of cultures
with "Cr-labeled allogeneic monocyte
targets . The E/T ratio of the MLR cultures was -30 :1 at the time the targets
were added . After a 4-h incubation, supernatants were harvested for determination of the percent specific release as
shown along the ordinate .

Downloaded from https://rupress.org/jem/article-pdf/171/4/1315/487882/1315.pdf by Rockefeller University user on 21 July 2020

Results

Dendritic Cells Induce the Development ofAntigen-specific CTL and NK Cells in the Absence
of CD4 + Helper Lymphocytes. It is widely accepted that the standard population of
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was the isotype-matched control for the OKM1 mAb. Panning with OKMI removed
the K562 cytolytic precursors without significantly altering the level of antigen-specific
killing (Fig. 2) . Note that the addition of PHA during the CTL assay did not appreciably augment the measurable lysis by CD4 - /CDllb - effectors from the allogeneic MLR (Fig. 2). However, PHA did enhance killing by a lectin-dependent
mechanism by the bulk and CD4 - /CD14 - populations that contained nonspecific
lytic cells. The CTL assay therefore efficiently detected all of the antigen-specific
CTL response that developed from the allogeneic MLR, and these effectors developed primarily from the CD4 - /CDllb - T cell precursors.
In dose-response studies (Fig. 3) we noted that very low levels of dendritic cells
were required to induce NK cell activity, whereas higher levels were required for
the induction of CTL. Typically the required ratio of dendritic cells to T cells was
1 :10 or 1 :30. These doses are much higher than the number ofdendritic cells present
if bulk mononuclear cells were used as stimulators of CD4+ -independent CTL responses.
As in the mouse, helper-independent CD4 - responses to histoincompatible dendritic cells usually peaked -24 h earlier than those of a bulk T cell population containing CD4+ helper lymphocytes (Fig . 4, A and B). The kinetics were identical
regardless of the CD4 - subset used as responders (data not shown) . In syngeneic
MLRs cultured in 10 01o human serum, only bulk T cells exhibited any measurable
proliferation (Fig. 4 A), although it was markedly less than after allogeneic stimulation . FCS supported a greater syngeneic response by both T cell populations (data
not shown), and we have therefore avoided its use in functional assays .
We conclude that allogeneic dendritic cells can induce the formation of antigenspecific and -nonspecific cytolytic cells in the absence of CD4 + helper lymphocytes.
The precursors ofnonspecific NK/LAK type cells can be removed by panning with
an anti-CDllb mAb, OKMI, without altering the amount of antigen-specific CTL
that develops in the allogeneic CD4 - MLR. The kinetics of the CD4 - response are
rapid, and a syngeneic response is not observed by CD4- lymphocytes when cultured in human serum. These findings are representative ofmore than 15 experiments.
CD4 + T Lymphocyte Contaminants Do Not Contribute to the CD4- MLR . With even
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low levels of CD4+ contamination (e.g., <2-3% as shown in Fig. 1), helper lymphocytes could proliferate disproportionately during the CD4- MLR and contribute to the primary cytolytic responses illustrated above. We therefore phenotyped the responder lymphocytes after dendritic cell stimulation in the allogeneic
MLR. Cytofluorographic data confirmed the continued purity of the starting
CD4-/CD14- and CD4-/CD11b - populations (Fig. 5). Note the presence of a trace,
but discrete subpopulation of S chain-positive T cells, comprising N3% of both
CD4- lymphocyte populations. These cells were also present to a similar degree
before stimulation (data not shown) .
One of the hallmarks of CD4+ lymphocyte function is the production of T cell
growth factor[s] [TCGF], among which is IL-2 . However, in the "helper-independent"
CD4- allogeneic MLR measurable amounts of TCGF were also found (Fig . 6). To
exclude the production of significant amounts of IL-2 by trace contaminant CD4+
T lymphocytes, responder populations of bulk T lymphocytes and purified CD4 lymphocytes were coated with anti-CD4 (Leu3a, 3 hg/ml final) and then stimulated
with allogeneic DCs in the continuous presence of anti-CD4. Responder populations stimulated in the absence of anti-CD4 were cultured in parallel . We then compared supernatants harvested at serial time points from these MLRs with graded
doses of rIL-2 for their ability to support the growth of CTLL2 cells (12). TCGF
was readily detected in the allogeneic MLR when bulk T lymphocytes were stimulated by blood dendritic cells, and there was a 75% reduction when the bulk T cell
responders were coated with anti-CD4. Smaller amounts of TCGF were present in
the dendritic cell-stimulated CD4 - MLR, but there was no significant inhibition
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DAY of the SYNGENEIC MLR

Kinetics of the primary
human MLR elicited by blood dendritic cells . Bulk T lymphocytes and
CD4 -/CDllb - T cells were stimulated
in U-bottomed microwells (responder/
stimulator of 10 :1) by syngeneic or allogeneic dendritic cells (3,000 rad,
13 ~Cs) in the respective MLRs cultured in RPMI-10% NHS. On the day
of culture indicated along the abscissa,
the cultures were pulsed with 1 FACT/
well of [ 3 H]TdR for 6-8 h and
proliferation was measured in standard
fashion (A : bulk T lymphocyte responders, " ; CD4- /CDllb- responders, O) . Concomitantly, 5 x 103
51 Cr-labeled syngeneic or allogeneic
monocytes were added to separate
MLR microwells, and supernatants
were harvested and counted after 4 h
for determination of percent specific
slCr release (B: allogeneic Mo targets,
" ; syngeneic Mo targets, A).
FIGURE 4 .
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6. Production of T cell
growth factor(s) by CD4 - lymE
phocytes in the helper-indepen
w
dent allogeneic MLR . Bulk T
lymphocytes ( " ) and CD4lymphocytes (/) were coated
z
(Leu3a
°-°
with an- fl
, 3 Ag/ml
final) and then stimulated with
Zw
allogeneic dendritic cells in the
. Bulk r : DC + anti-CD4
continuous presence of anticos+/
w
coa - ,
DG
CD4 . UnCOated lymphocytes
CD4 -, CDa+/ DC + anti-CD4
were stimulated and cultured
alongside in the absence of antiCD4 (bulk T, O ; CD4 - , p) .
ALLOGENEIC MLR, H
Supernatants were harvested at
serial time points and tested for
their ability to support the growth of the CTLL2 cell line (12). Activity is reported in units derived
from a standard curve with graded doses of human rIL-2 . In different experiments the absolute amounts
of measurable TCGF were not always the same, but the results were qualitatively similar, i .e., anti-CD4
significantly reduced the amount of TCGF produced by bulk T cells but not by CD4 - lymphocytes,
regardless of the CD4 - subset stimulated .
° Bulk T / DC

FIGURE
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ofthese negatively selected responders by anti-CD4. [3H]TdR incorporation by responder lymphocytes was also measured in allogeneic MLR cultures run in parallel .
Anti-CD4/Leu3a in this concentration inhibited proliferation by bulk T cell responders
by 45%, whereas it had no significant effect on [3H]TdR incorporation by CD4responders in the "helper-independent" allogeneic MLR. Similar findings have been
obtained using the more highly purified CD4-/CDllb - subset (data not shown).
Large Numbers of CD4 -/CD11b - Lymphocytes Display Phenotypic Markers ofActivation
after Stimulation by Histoincompatible DCs. We phenotyped responding lymphocytes
in the MLR for activation markers such as the receptor for IL2 (17), the expression
of class II MHC (18, 19), and the absence of the CD45R epitope (20, 21) on the
large lymphoblasts . CD4 - /CDllb - T cells exhibited these phenotypic markers of
activation only after primary stimulation by allogeneic dendritic cells (Fig. 7 A) .
Neither allogeneic monocytes (Fig. 7 B) nor syngeneic DCs (not shown) could elicit
such activation markers, the staining for which was the same as the background staining
of unstimulated CD4 -/CDllb - T cells (Fig. 7 C. Representative cytofluorographs
of allogeneic dendritic cell-stimulated bulk T lymphocytes are shown for comparison (Fig. 7 D). We ascertained that large, IL-2R+ cells comprised 43% of the alloreactive lymphocytes in the bulk T cell MLR and 33% of the alloreactive lymphocytes in the CD4-/CDllb - cells MLR after a 4-5-d culture. This is representative
of more than six experiments.
BloodDendntic Cells Are theMost Active Accessory Cellsfor Unsensitized CTL Precursors. We
evaluated the APC requirements for a primary response by resting, naive CTL
precursors (CTLp) in the absence of CD4 + T cell help. Candidate APC populations were obtained as described (Materials and Methods; reference 11), irradiated
(3,000 rad, "'Cs), and added at different doses to negatively selected bulk CD4 lymphocyte responders in 16mm macrowells . At peak proliferation in the MLR on
day 4-5, the cells were harvested and added to radiolabeled monocytes at the indicated E/T ratios ; "Cr release was measured after 4 h (13). As shown in Fig. 8, den-
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Large numbers of
CD4-/CDllb - lymphocytes
display activation markers after
stimulation by histoincompatible dendritic cells in the helperindependent MLR. CD4-/
CDllb- T cells were stimulated
by allogeneic dendritic cells (A)
or allogeneic monocytes (B)
(responder/stimulator of 10 :1)
for 4-5 d in U-bottomed microwells. Unstimulated CD4"/
CDllb- T cells (C) and allogeneic dendritic cell-stimulated
bulk T lymphocytes (D) (responder/stimulator of 10 :1)
were cultured simultaneously
for comparison. At peak proliferation, the MLRs were
stained directly in the U-bottomed microwells with the indicated mAbs and analyzed by
cytofluorography. Negative controls stained with FITC-goat
anti-mouse Ig but no primary
mAb are illustrated in the far
left column .
FIGURE 7 .
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dritic cells were the most active APC for stimulating cytolytic effector function in
a dose-dependent fashion and in the absence of CD4 + help .
We have previously reported that peritoneal macrophages could inhibit a primary
CD8+ response in the murine system (9). However, this was not the case using primary leukocyte isolates from human blood. Monocytes did not inhibit the dendritic
cell-stimulated response even at high doses (Fig . 8) . Similar findings pertained when
bulk T cells, comprised of both CD4 + and CD8 + responders, were assayed for primary cytolytic activity after allogeneic stimulation in the MLR (data not shown) .
We have similarly examined the APC requirements for more highly purified
CD4 - populations depleted of CD11b+ NK/LAK precursors, with regard to both
proliferation and cytolytic activity . Blood dendritic were the most active APCs for
stimulation of both proliferation and cytolysis (Fig . 9, A and B) . The bulk Er - population and the Er-FcR- populations contained a lower proportion of dendritic cells,
and these stimulators elicited lower but measurable responses at the higher dose .
Monocyte depletion did not abrogate the observed responses, and adherent Er - cells
specifically enriched for monocytes did not display significant stimulatory capacity.
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Comparison of APC activity in
eliciting primary CTL from CD4- allogeneic
lymphocytes . CD4- lymphocytes were cultured
at 1.5 x 10 6 cells per 16-mm macrowell and
stimulated with different APC populations at the
indicated stimulator/responder ratios. At the end
of day 4, the responding lymphocytes in the
MLRs were harvested from the microwells,
counted, and added to triplicate U-bottomed
microwells for assay of CTL activity against 10 4
5'Cr-labeled allogeneic M0 from the original
stimulator party. Supernatants were harvested
after a 4-h incubation and percent specific release
was calculated in standard fashion. Small B lymphocytes or bulk PBMCs (not shown) were no
more active as stimulators in the helper-independent CD4 - MLRs than were monocytes.
FIGURE 8.

Whether monocytes were used fresh or after 2 d of culture in 10% human serum
did not affect their function as APCs for unsensitized precursors (data not shown) .
Bulk mononuclear cells or small B lymphocytes were similarly inactive in eliciting
primary proliferative and cytolytic responses (data not shown) .

Blood Dendritic Cells, but notMonocytes, Stimulate the Development of Nonspecific Cytolytic
Lymphocytes. Antigen-nonspecific NK cells are dependent on lymphokine for their
activation and development (22-24). We therefore compared the capacity of blood
dendritic cells and monocytes to sensitize NK cell precursors in a bulk T cell popu-

Comparison of APC activity in
eliciting primary responses by CD4-/CDllb - T
cells in the helper-independent allogeneic MLR.
CD4-/CDllb - lymphocytes were stimulated in
U-bottomed microwells by the indicated APC
populations [Bulk Er - , l ; adherent Er - ,
=; Er-FcR- , ®; dendritic cells, 0) . The
responder/stimulator doses illustrated are 10 :1
(left) and 30 :1 (right). At the end of day 4, the
microwells were pulsed with 1 p,Ci/well of
[ 1H]TdR for 6-8 h and incorporation was measured as an index of proliferation (A). Concomitantly, 5 x 10' ' ICr-labeled allogeneic M0
targets were added directly to separate MLR
microwells for a standard 4-h CTL assay (B).
FIGURE 9 .
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lation where the amount of lymphokine would not be limiting . As shown in Table
I, the percent specific lysis of K562 targets correlated directly with the stimulatory
dose of histoincompatible dendritic cells and the amount of proliferation. Monocytes were neither active by themselves, nor inhibitory in combination with dendritic cells, in stimulating lytic effectors against K562 targets.
As in the mouse (7, 9),
resting human lymphocytes that are extensively depleted of CD4 + cells can be induced by blood dendritic cells to synthesize DNA and develop cytolytic activity. In
both species CD4 + lymphocyte depletion is sufficiently complete that helper cells
are not detectable at the onset or during the CD4 - MLR, and the responses are
not inhibited by anti-CD4 mAb. T cell growth factors are produced in both human
and murine CD4- MLRs . However, the magnitude and longevity of lymphokine
production and T cell growth are less than observed in populations containing
CD4' lymphocytes.
Other types of APCs in human blood, as in mouse spleen, are weak or inactive
in stimulating the CD4 - MLR. Typically, the required ratio of dendritic cells to
T cells (e.g., 1 :10 or 1 :30) is much higher than the number of dendritic cells that
are present when bulk mononuclear cells are used as stimulators. This probably
accounts for the fact that CD4 + -independent cytolytic responses have not been previously described in the human.
The significance of the CD4 - MLR is enhanced by experiments in vivo in the
mouse that have shown that resistance to some infectious agents (6) and tumors (25)
can develop in the apparent absence of CD4 + T cells. For example, elimination of
CD4 + function by in vivo administration of anti-CD4 mAb has little effect on an
animal's capacity to develop CTL and to survive infection with ectromelia virus (6),

TABLE I

Blood Dendritic Cells, but not Monocytes, Stimulate Development of
K562 Lytic Cells in the Primary Allogeneic MLR

0
1
1
Percent specific 51 Cr release against
K562 targets, day 4 of the MLR
[ 3 H]TdR x 6 h, day 4 of
the MLR

DC
Mo

Dose of allogeneic stimulators [3,000 rad, " Q Cs]
added at time 0 to 1 .5 x 105 BULK Er'
NyW NA lymphocytes
1 .5 x 104
.0 x 10 4
.5 x 104
.0 x 104
.5 x 10 4
0
0 .5 x 10 4
36%
5%
44%
42%
55,674

53,874

48,079

5,086

1 .5 x 10 5 bulk T (Er' NyW NA) lymphocytes were stimulated in U-bottom microwells by dendritic cells
(DC) or adherent Er - monocytes (Mo) . The DC or Mo were added either alone or in combination at the
doses indicated . On day 4, 5 x 10 5 'Cr-labeled K562 cells were added to the microwells, and supernatants
were harvested after a 4-h incubation for determination of percent specific release. A parallel group of cultures was pulsed for 6-8 h also on day 4, with 1 1ACi/well of [ 3 H]thymidine to measure proliferation .
DC, blood dendritic cells . M0, blood monocytes . Er' NyW NA, SRBC rosette-positive, nylon wool nonadherent lymphocytes .
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Discussion

Similar Features of the Murine and Human CD4- MLRs.
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Antigen-speck CTL and Antigen-nonspecific NK Cells Generated in the Dendritic Cellstimulated, Helper-independent CD4- MLR. During the CD4 - MLR, lytic cells de-

velop that kill allospecific targets from the original stimulator as well as nonspecific
targets such as K562 . The latter are standard targets for NK cells. Precursors of
these nonspecific lytic effectors can be depleted by panning with an anti-CD11b mAb,
a known marker of NK cells (26, 27). Anti-CD11b, but not a control anti-CD14 mAb,
removes a minor CD4- subset of CD11b+/CD28-, CD16' cells that is distinct from
the major CD11b-/CD28+ , CD16 - subset . Negative selection by panning with antiCDllb, however, does not significantly abrogate the antigen-specific CTL that develop in the helper-independent CD4 - MLR.
It is possible that the NK cells that develop in the CD4- MLR do so because dendritic cells express epitopes that are also carried by standard K562 targets. Alternatively, the amount of IL-2 secreted in the dendritic cell-stimulated CD4 - MLR may
be sufficient to support NK cell proliferation as a bystander event . NK cells are known
to expand in response to IL-2 ; but it is thought that expansion requires relatively
high doses of lymphokine, since NK cells predominantly express the p75 intermediate
affinity IL-2R (22-24) .
A Large Number of Lymphocytes Are Activated during the CD4- MLR by Allogeneic Dendritic Cell Stimulation . Several changes in surface phenotype are known to accom-

pany human T cell activation . These include the appearance of the p55 IL-2R (CD25)
(17) and MHC class II molecules (18, 19). Correspondingly, activated T lymphoblasts do not express a CD45R epitope (20, 21). Using mAb to these antigens to
monitor the extent of T cell stimulation at the single cell level, we find that at the
peak of the CD4-/CDllb - MLR, as many as 33°Io of the cells are enlarged T lymphoblasts expressing the activation phenotype CD25 +/HLA-DR,DQ+/CD45R-.
Activation antigens and an increase in cell size do not develop if the stimulator cells
are allogeneic monocytes or syngeneic dendritic cells.
The frequency of CD8+ T cells that respond to allogeneic dendritic cells seems
high, but can be explained if 1-10% of the CD8+ cells respond to allogeneic class
I MHC Ag and undergo two to five cell divisions in 4-5 d. This figure is consistent
with the number of T cells that can respond to a full allogeneic MHC difference
in the rat (28, 29).

AllogeneicMonocytesAre Unable to Stimulate, but also Do Not Inhibit the Helper-independent
CD4- MLR. Other candidate APCs, notably monocytes and small B cells, do not

elicit a primary MLR by CD4 - responders . Similar observations have been made
in the mouse, but in that species peritoneal macrophages also inhibit the function
of allogeneic dendritic cells (9). In man, blood monocytes are not inhibitory even
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even though the neutralizing antibody response to ectromelia is markedly suppressed.
One unknown in interpreting these data is whether dendritic cells are capable of
presenting peptides derived from ectromelia in association with class I. It is possible
that antigen presentation on class I molecules by dendritic cells efficiently primes
a CD8 + response in the absence of helper cells. If other APCs are the only source
of class I MHC-peptide complexes during an immune response, there may be a
greater need for helper cells reactive with class II MHC-peptide complexes.
There are new features and implications, however, that have become evident in
the human CD4 - MLR that were not apparent in the murine system . We will
discuss several of these.
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Implications of CD4+ -independent Cytolytic Lymphocyte Responses for Transplantation. CTL directed against major and minor histocompatibility differences have

been implicated in graft-vs-host disease (GVHD) in both animal and human models
(34-39). Murine CD4 + (class II MHC restricted) and CD8+ (class I MHC restricted) cells can both contribute to GVHD, although the relative contribution of
each subset varies with the minor histocompatibility antigens under study (40). Despite apparent HLA identity and MLR compatibility, GVHD and graft rejection
remain well-recognized obstacles to the successful use of human allogeneic bone
marrow transplantation (41-44). The potential causes are legion, but include class
I major and possibly minor histocompatibility differences that would be undetected
by available serologic reagents or by standard MLR testing in which bulk mononuclear
cells are used as stimulators.
Since alloreactive CD8+ T cells are detected in high frequency when dendritic
cells present allogeneic class I molecules, it may be more efficient to detect subtle
class I MHC incompatibilities using dendritic cells rather than bulk mononuclear
cells as stimulators. We have recently made several improvements in our dendritic
cell enrichment protocol so that yield and purity similar to that obtained from leukocyte concentrates can be derived from 50-100 ml peripheral blood samples (our
unpublished data). The use of CD4- responder populations would also focus the
analysis on class I MHC incompatibilities that might otherwise be obscured by a
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at high monocyte/dendritic cell ratios (3.3:1). Sprent and Schaefer have described
a particular set of experimental conditions whereby certain populations of mouse
macrophages can stimulate DNA synthesis in CD4 - lymphocytes (30) . It is unlikely
that their populations were contaminated with dendritic cells, since the stimulators
did not induce a CD4+ MLR. However, in man the blood monocyte population
is consistently without APC activity for the primary MLR, whether used freshly
isolated from blood or after 2 d ofculture on Teflon-coated surfaces in human serum.
These apparent species differences may reflect a potential role for macrophage-derived
cytokines that may have been present in the experiments of Sprent and Schaefer.
Monocytes are capable ofclass I alloantigen presentation since they can be recognized as specific targets by sensitized CD8+ CTL (13, 31) elicited by dendritic cells.
However, while naive, unsensitized CTLp form discrete aggregates with allogeneic
dendritic cells that are easily seen by microscopy within the first 12-24 h ofculture,
we observe little if any monocyteT cell cluster formation in our cultures . All of the
specific CTL response in the allogeneic MLR develops from these clustered
CTLp-dendritic cell aggregates, which can be separated from the nonclustering,
nonreactive lymphocytes by velocity sedimentation (our unpublished data). The lack
of primary stimulatory function in monocytes may therefore be at the level of contact formation between the APC and the resting, or unprimed CD8+ T cell. These
observations are consistent with many prior studies of CD4+ T cell responses in
which one ofthe distinct features ofdendritic cells as APCs is their capacity to identify and bind antigen-specific lymphocytes from a pool of resting precursors (32,
33). We have tested whether our culture conditions may limit monocyte-T cell contact by virtue of the fact that monocytes adhere to tissue culture plastic. However,
we have cultured CD4- MLRs in small Teflon beakers to which monocytes do not
adhere, and we have still not observed clustering or a productive CD8 + response
(our unpublished data).
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Summary
Cytotoxic lymphocytes are typically generated from unfractionated suspensions
of human lymphocytes by stimulating with heterogeneous APCs and exogeneous
growth factors. We have found that human blood dendritic cells can directly stimulate allogeneic human CD8' T cells to proliferate and express antigen-specific cytotoxic activity. These primary responses, which are accompanied by the release of
T cell growth factor(s), are induced in the absence of CD4+ helper T cells and are
not inhibited by anti-CD4 mAb. Both antigen-specific CTL as well as nonspecific
NK cells can be elicited by dendritic cells . The NK cell response can be depleted
at the precursor level by panning with an anti-CDllb mAb, which removes a
CD11b +/CD28- , CD16' subset from the starting CD4 - responders. Allogeneic
blood monocytes are neither stimulatory nor inhibitory of these primary CD4MLRs, even though monocytes present alloantigen in such a way as to be recognized as specific targets for CTL that have been sensitized by dendritic cells. The
number of CD8+ cells that are blast transformed and express an activated phenotype (i .e., HLA DR/DQ+, CD25/IL-2R+, CD45R -) reaches 30-40% of the culture at day 4-5, the peak of the helper-independent response. We conclude that antigenpresentation by dendritic cells is sufficient in itself to prime cytolytic precursors.
We speculate that using dendritic cell stimulators and CD4- responders in MLRs
may be more efficient than standard tissue typing approaches for the detection of
subtle, but important class I MHC-restricted histoincompatibilities in human transplantation .
We express our appreciation to Lynne Wu, Steve Soergel, and Mary Crowley for technical
assistance; to Judy Adams for assistance with graphics; and to Jeffrey Ming and Drs . Nina
Bhardwaj and Angela Granelli-Piperno for helpful review and discussion of the manuscript .
Received for publication 7 Decernber 1989.
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